SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq: ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or “smile line” wrinkles, today announced it will present at the 26th Annual JP Morgan Healthcare Conference on Thursday, January 10, 2008 at 11:30 a.m., Pacific Time, at The Westin St. Francis in San Francisco, CA.
